An experimental treatment for Multiple Sclerosis recently hit its five-year mark with promising results. MS causes the immune system to target the body’s own nerve fibers and their myelin layer. The resulting damage causes a variety of symptoms such as chronic pain, exhaustion, weakness, impaired coordination, and speech difficulties. Relapsing-remitting MS is the most common form of MS with symptoms chronically ranging from minor to extreme.
HDIT/HCT, or “high-dose immunosuppressive therapy and autologous hematopoietic cell transplant,” attempts to reboot the patient’s immune system with a one-time treatment. Blood-forming stem cells are harvested, then high-dose chemotherapy is used to disable the compromised immune system, followed by re-injecting the harvested stem cells to reset the system.
The trial, HALT-MS, consisted of 24 volunteers aged from their twenties to fifties. Each suffered from relapsing-remitting MS that resisted standard treatment. After 5 years, 69 percent of the subjects experienced no progression or relapse, and no new brain lesions.
According to other studies, the HALT-MS results surpassed that of currently available MS drug treatments. This indicates a one-time HDIT/HCT treatment may be more effective than existing treatments. Larger studies are needed to confirm, but HALT-MS is an excellent beginning.
Doctor Shiva Gopal Vasishta, MD is a physician in Voorhees, New Jersey with over 38 years of experience in Neurology and Psychiatry, including MS. Dr. Vasishta completed his residency at Tufts Medical Center and Boston University Medical Center. He holds his license with the state of New Jersey.
Shiva Vasishta participates in the Medicare program. Under Medicare, a patient will only be billed for the authorized deductible and co-insurance. Medicare billing is done through Eastern Neurodiagnostic Assoc Pc.
Dr. Shiva Gopal Vasishta’s office number is (856) 651-0060, and his offices are located at 2301 Evesham Rd, Pavillion 800 Suite 209, Voorhees, NJ 08043.